Granite Point Capital Management’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Granite Point Capital Management’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-29,300	Closed	-$715K	–	134
2017 Q4	$715K	Sell	29,300 -25,000	-46%	-$481K	0.07%	72
2017 Q3	$1M	Hold	54,300	–	–	0.21%	57
2017 Q2	$899K	Buy	+54,300	New	+$755K	0.22%	65

Granite Point Capital Management's ENTL Position: Q1 2018 in Review

Granite Point Capital Management sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 29,300 shares — an estimated $715K sold.

Granite Point Capital Management first reported a position in ENTL in Q2 2017 and held it in 3 quarters. The position peaked at $1M in Q3 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Granite Point Capital Management reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Granite Point Capital Management sold 29,300 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $715K.
Granite Point Capital Management first reported a position in Entellus Medical, Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Granite Point Capital Management's Entellus Medical, Inc. Common Stock position peaked at $1M in Q3 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Granite Point Capital Management's 13F filing for Q1 2018, filed 15 May 2018.